A Response to: Letter to the Editor Regarding “Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance” - Bogdan Batko; Jose L. Rivas (Rheumatology and Therapy)